Similar Articles
1091 Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
1092 Liver transplantation as a management of hepatocellular carcinoma
1093 Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
1094 Current systemic treatment of hepatocellular carcinoma: A review of the literature
1095 Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
1096 Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
1097 Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis
1098 Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis
1099 Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma
1100 Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA